Preparation method and application of boron affinity imprinting COF microsphere adsorbent
Boron-affinity-blotting COF microspheres were prepared by Pickering emulsion interface assembly and surface-initiated polymerization technology, which solved the problems of poor selectivity and low yield in naringin extraction, and achieved efficient, rapid specific separation and good adsorption performance of naringin.
Patent Information
- Application Number
- CN202411172822.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The extraction methods of naringin (NRG) in existing pomelo peels have poor selectivity, low target product yield and low reuse rate. The traditional separation and enrichment methods cannot effectively achieve rapid specific separation of naringin.
Porous covalent organic frame (COFs) microspheres were prepared by the Pickering emulsion interface assembly strategy, and boron-affinity blot COF microspheres were prepared by surface-induced atom-transfer radical polymerization (SI-ATRP) method for selective separation of naringin . The method includes the synthesis of BTCA-COF@PDA particles, the formation of microspheres, the preparation of initiators and the use of boric acid monomers, to construct multi-layer boric acid binding sites, and to improve adsorption performance.
The high affinity, good adsorption capacity, fast adsorption kinetics and good regeneration performance of naringin have been achieved, which significantly improves the selective separation and purification efficiency of naringin.
Smart Images

Figure CN119034695A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of preparation of environmental functional materials, and relates to a preparation method and application of a cross-linked porous boron affinity microsphere molecular imprinting adsorbent at an emulsion interface. Background Art
[0002] As a natural flavonoid compound, naringin (NRG) has a variety of biological activities and pharmacological effects, and is widely used in the medical field, such as cardioprotection, cholesterol reduction, anti-Alzheimer's disease, renal protection, anti-aging, anti-hyperglycemia, anti-osteoporosis, antioxidant, anti-cancer and anti-ulcer effects. At present, many methods have been widely used to separate and purify NRG from pomelo peel. Commonly used extraction methods mainly include alkali extraction and acid precipitation, ultrasonic assisted extraction, microwave assisted extraction, crystallization, solvent extraction, adsorption, etc. These methods have their own advantages and disadvantages, but their common defects are poor selectivity, low yield of target products and low reuse rate. Boron affinity molecular imprinting adsorbents have gradually become important adsorbents for the separation and enrichment of ortho-dihydroxy compounds. The mechanism of action of boron affinity is based on the reversible covalent interaction between the cis-dihydroxyl group of the compound and the boric acid group. By changing the pH value in the system, the binding mode of the boric acid functional group and the cis-dihydroxyl group is affected, thereby achieving reversible adsorption and release of ortho-dihydroxyl compounds. Molecular Imprinting Polymers (MIPs) are tailor-made synthetic receptors with highly specific recognition properties for template molecules. Based on the "lock and key" mechanism, MIPs provide excellent targeting capabilities in terms of size, shape and functional groups, and therefore have gained great attention as advanced materials. However, the limited surface area restricts the number of imprinted sites, resulting in poor adsorption performance. Therefore, the recognition ability and adsorption performance can be enhanced by introducing covalent organic frameworks as carriers. Covalent organic frameworks (COFs) are highly ordered porous crystalline polymers with strong covalent bonds. They have superior properties such as high functional adjustability and excellent water / chemical stability, and are widely studied as adsorbents for water / wastewater treatment. Microspheres (MCs) are microparticles with a hollow structure, consisting of a solid shell surrounding a core-forming space that can permanently or temporarily trap substances. They can effectively protect the sensitive and valuable active substances loaded in the internal water core from the influence of the surrounding environment, and have selective permeability and structural stability. They have a wide range of applications in targeted drug delivery, controlled release, selective separation, etc.
[0003] Pickering emulsion is an emulsion stabilized by solid stabilizing particles at the interface. In this method, solid particles are used as stabilizers in the emulsion system. They can adsorb at the interface of the oil-water phase and provide a strong physical barrier to prevent coalescence, giving the emulsion long-term stability. By adjusting the concentration and size of the solid particles at the water-oil interface, the size and stability of the emulsion droplets can be controlled. In recent years, Pickering emulsions have been widely used in the construction of porous separation materials due to their simplicity, low cost, scalability, and environmental protection. Summary of the invention
[0004] The present invention adopts the Pickering emulsion interface assembly strategy to prepare COFs microspheres, and prepares boron affinity imprinting adsorbents based on COFs microspheres for rapid and specific separation of NRG. First, COF microspheres (BTCA-COF@-MC) are prepared based on Pickering emulsion. The surface of COF microspheres is modified by dopamine to have a large number of hydrophilic amino groups, and then an ATRP initiator (Y-Shape-(Br) 2 Boron affinity imprinted COF microspheres (DR-MC@PDA@MIPs) were prepared by surface initiated atom transfer radical polymerization (SI-ATRP) using low pKa boronic acid monomer 1-allylpyridine-3-boronic acid (3-APBA) as functional monomer and preassembled with template molecule NRG. They were applied to the selective separation and purification of naringin.
[0005] The technical solution adopted by the present invention is:
[0006] The preparation method of the emulsion interface cross-linked porous boron affinity microsphere imprinted adsorbent comprises the following steps:
[0007] (1) Synthesis of BTCA-COF@PDA particles;
[0008] Dissolve 1,3,5-tris(4-aminophenyl)benzene and 1,3,5-triformaldehydebenzene in acetonitrile, add competitor benzaldehyde and aniline, mix the solution with acetonitrile containing scandium(III) trifluoromethanesulfonate, react at room temperature for 12-48 hours, collect the resulting product BTCA-COF, wash with acetonitrile and transfer to a vacuum oven for drying;
[0009] BTCA-COF was added to a mixture containing ethanol and Tris buffer (pH = 8.5), the solution was ultrasonically dispersed, and then dopamine hydrochloride was added under magnetic stirring. The reaction was carried out at room temperature for 5-10 hours, and then washed three times with ethanol, centrifuged, and vacuum dried to obtain BTCA-COF@PDA black powder.
[0010] In step (1), the ratio of 1,3,5-tris(4-aminophenyl)benzene, 1,3,5-triformaldehydebenzene, benzaldehyde, aniline, and scandium(III) trifluoromethanesulfonate is (17-36) mg: (8-17) mg: (60-125) μL: (50-120) μL: (10-25) mg;
[0011] The dosage ratio of BTCA-COF and dopamine hydrochloride is (10-20) mg: (10-20) mg;
[0012] (2) Synthesis of microsphere BTCA-COF@PDA-MC;
[0013] First, when preparing COFs particle-stabilized Pickering emulsion, BTCA-COF@PDA was ultrasonically dispersed in trimethyltoluene as the oil phase; then, scandium (III) trifluoromethanesulfonate was dissolved in deionized water to obtain a scandium (III) trifluoromethanesulfonate aqueous solution as the aqueous phase, which was dropped into the oil phase and emulsified under high-speed shear stirring to obtain a stable W / O Pickering emulsion.
[0014] Then, the above emulsion and trimethyltoluene were added into a centrifuge tube to obtain an emulsion dispersion; 1,3,5-tri(4-aminophenyl)benzene and 1,3,5-triformaldehydebenzene BTCA were dissolved in chloroform, and then benzaldehyde and aniline were added to obtain a mixture; the mixture was added into the emulsion dispersion, and after polymerization at room temperature, microspheres were collected and washed several times with tetrahydrofuran and ethanol to obtain microspheres BTCA-COF@PDA-MC.
[0015] In step (2),
[0016] The dosage ratio of BTCA-COF@PDA, trimethyltoluene, and scandium (III) trifluoromethanesulfonate aqueous solution is (1.7-3.4) mg: (4-8) mL: (200-400) μL; wherein the concentration of the scandium (III) trifluoromethanesulfonate aqueous solution is 7.3 mg / mL;
[0017] The usage ratio of W / O Pickering emulsion, trimethyltoluene, 1,3,5-tris(4-aminophenyl)benzene, 1,3,5-triformaldehydebenzene, chloroform, benzaldehyde, and aniline is (2-4) mL: (4-8) mL: (3.5-7.0) mg: (1.6-3.2) mg: (2-4) mL: (12.1-24.2) μL: (10.8-21.6) μL;
[0018] (3) Initiator (Y-Shape-(Br) 2 ) and the synthesis of 1-allylpyridine-3-boronic acid (3-APBA);
[0019] Add 2,2-di(hydroxymethyl)propionic acid, triethylamine and tetrahydrofuran into a round-bottom flask with a magnetic bar, cool in an ice bath, drop 2-bromoisobutyl bromide dissolved in tetrahydrofuran into the flask, stir at room temperature for 1-3 hours, after the reaction is completed, filter out the formed solid, evaporate the solvent, dissolve the residue in dichloromethane, add deionized water, stir at 40-60°C for 1-3 hours, separate the organic layer, extract several times, and remove the solvent to obtain a white solid initiator Y-Shape-(Br) 2 ;
[0020] Pyridine-3-boric acid and allyl bromide are dissolved in ethanol and reacted in a nitrogen atmosphere at 100-150° C. for 12-36 hours. After the reaction is completed, the solvent and unreacted allyl bromide are removed in vacuo to obtain 3-APBA.
[0021] In step (3),
[0022] The usage ratio of 2,2-di(hydroxymethyl)propionic acid, triethylamine, 2-bromoisobutyl bromide and total tetrahydrofuran is (2.0-4.0) mg: (5-10) mL: (3-9) mL: (30-60) mL;
[0023] The usage ratio of pyridine-3-boric acid, allyl bromide and ethanol is (200-400) mL: (400-800) mg: (50-100) mL;
[0024] (4) Synthesis of DR-MC@PDA@MIPs microspheres;
[0025] First, the BTCA-COF@PDA-MC prepared in step (2) was added to a mixture containing ethanol and Tris buffer (pH=8.5), and then dopamine hydrochloride was added under magnetic stirring. After reacting at room temperature for 8-16 hours, the microspheres were washed with ethanol and dopamine functionalized microspheres, i.e., MC@PDA, were collected.
[0026] Then, the Y-Shape-(Br) prepared in step (3) 2 Dissolve in ethanol, add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and n-hydroxysuccinimide (NHS), react for 5-10 min, then add MC@PDA dispersed in deionized water, stir at 25-45 °C for 10-15 h to obtain MC@PDA-Br, and wash with ethanol and deionized water several times;
[0027] The synthesized low pKa boronic acid monomer 3-APBA and naringin NRG were dispersed in a mixed solvent of methanol and N,N-dimethylformamide, and then MC@PDA-Br was added. The mixture was magnetically stirred under nitrogen protection, and copper dichloride and N,N,N',N",N"-pentamethyldiethylenetriamine were added in sequence. After 10 to 15 minutes, ascorbic acid was added, and molecular imprinting polymerization was initiated by SI-ATRP at room temperature for 10-15 hours. Finally, the template NRG was removed with a mixture of methanol / acetic acid (v:v, 9:1), washed with water and ethanol, and dried in vacuum to obtain DR-MC@PDA@MIPs, i.e., boron affinity imprinted COF microsphere adsorbent.
[0028] For comparison, non-imprinted polymers (DR-MC@PDA@NIPs) were prepared using the same method without the addition of NRG.
[0029] In step (4),
[0030] The dosage ratio of BTCA-COF@PDA-MC, ethanol, Tris buffer and dopamine hydrochloride is (20-40) mg: (10-20) mL: (10-20) mL: (20-40) mg;
[0031] Y-Shape-(Br) 2 , ethanol, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and n-hydroxysuccinimide in a ratio of (50-100) mg: (10-20) mL: (20-40) mg: (10-20) mg;
[0032] The dosage ratio of 3-APBA, naringin, methanol and N,N-dimethylformamide is (1.2-2.4) mg: (29-38) mg: (5-10) mL: (5-10) mL;
[0033] The usage ratio of cupric chloride, N,N,N',N",N"-pentamethyldiethylenetriamine and ascorbic acid is (1.3-2.7) mg: (1.7-3.5) mg: (3.5-7.0) mg.
[0034] The boron affinity imprinted COF microsphere adsorbent prepared by the invention is used for the selective separation of flavonoid compounds.
[0035] Furthermore, the boron affinity imprinted COF microsphere adsorbent prepared by the present invention is used for the selective separation of naringin.
[0036] The beneficial effects of the present invention are:
[0037] The present invention prepares COF microspheres with controllable structure, porous multi-shell and uniform surface imprinting sites. In addition, based on the hyperbranching effect of the novel initiator Y-Shape-(Br)2, abundant multi-layer boric acid binding sites are constructed on the microspheres, and the material has high affinity and good adsorption capacity for NRG, high adsorption capacity, fast adsorption kinetics and good regeneration performance. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 A scanning image of the covalent organic compound BTCA-COF particles prepared in Example 1 (a 1 , a 2 ) and scanning images of BTCA-COF@PDA particles (b 1 , b 2 );
[0039] Figure 2 The scanning image (a) of COF microspheres (BTCA-COF) prepared in Comparative Example 1 1 , a 2 ), a scanning image of the boron affinity microsphere molecular imprinting adsorbent (DR-MC@PDA@MIPs) prepared in Example 1 (b 1 , b 2 ); and the scanning image of the boron affinity microsphere non-imprinting adsorbent (DR-MC@PDA@NIPs) (c 1 , c 2 );
[0040] Figure 3 The initiator Y-Shape-(Br) prepared in Example 1 2 H NMR spectra of (a) and 1-allylpyridine-3-boronic acid (b);
[0041] Figure 4 This is the energy spectrum analysis diagram of the boron affinity microsphere molecular imprinting adsorbent (DR-MC@PDA@MIPs) prepared in Example 1;
[0042] Figure 5 It is the adsorption kinetic curve of the boron affinity microsphere molecular imprinting adsorbent (DR-MC@PDA@MIPs) prepared in Experimental Example 1;
[0043] Figure 6 (a) and (b) are the adsorption isotherm curves of the boron affinity microsphere molecular imprinting adsorbent (DR-MC@PDA@MIPs) and the boron affinity microsphere non-imprinting adsorbent (DR-MC@PDA@NIPs) in Experimental Example 2, respectively;
[0044] Figure 7This is the competitive adsorption bar chart of boron affinity microsphere molecular imprinting adsorbent (DR-MC@PDA@MIPs) in Experimental Example 3. DETAILED DESCRIPTION
[0045] The recognition performance evaluation method of the specific embodiment of the present invention is as follows: using the static adsorption experiment method, a certain amount of modified boronic acid imprinted polymer adsorbent and modified boronic acid non-imprinted polymer adsorbent are respectively added to 5 mL of a certain concentration of NRG solution, placed in a constant temperature water area of 35°C and shaken for several hours, and after adsorption, the residual NRG content is measured by a UV-visible spectrophotometer, and the adsorption capacity is calculated based on the results; after the adsorption reaches saturation, the adsorbent is collected by centrifugation, and several hydroxyl compounds with similar structures and properties to naringin are selected as competitive adsorbents to participate in the study of the recognition performance of the polymer.
[0046] The present invention will be further described below in conjunction with the accompanying drawings of the specific embodiment description.
[0047] Comparative Example 1
[0048] (1) Synthesis of BTCA-COF particles;
[0049] 1,3,5-Tris(4-aminophenyl)benzene (17.6 mg) and 1,3,5-triformaldehydebenzene (8.1 mg) were dissolved in 39 mL of acetonitrile. Competitors benzaldehyde (60.8 μL) and aniline (54.4 μL) were added. The solution was mixed with 1 mL of acetonitrile containing 11.8 mg of scandium (III) trifluoromethanesulfonate and reacted at room temperature for 24 h. The resulting product (BTCA-COF) was collected, washed with acetonitrile three times, and then transferred to 60 ° C for vacuum drying for 24 h.
[0050] (2) Synthesis of BTCA-COF microspheres;
[0051] First, when preparing COFs particle-stabilized Pickering emulsion, 1.7 mg BTCA-COF was dispersed in 4 mL of trimethyltoluene using ultrasound. Then, 7.3 mg of scandium (III) trifluoromethanesulfonate was dissolved in 1 ml of deionized water as the aqueous phase. Starting from the aqueous phase, 200 μL was dropped into the above mixture and emulsified for 3 minutes under shear stirring at 15,000 rpm to obtain a stable W / O Pickering emulsion.
[0052] Then, take 2 ml of the above emulsion (containing 100 μL of aqueous phase) and add it to a centrifuge tube together with 4 ml of trimethyltoluene. Dissolve 3.5 mg of BTCA of 1,3,5-tris(4-aminophenyl)benzene and 1,3,5-triformaldehydebenzene in 2 mL of chloroform, and then add 12.1 μL of benzaldehyde and 10.8 μL of aniline. Add the mixture to the emulsion dispersion. Adjust the density of the solvent to about 1 g / cm3 by adding chloroform and trimethylbenzene. Polymerize at room temperature for 24 hours. Finally, collect the microspheres, wash them several times with tetrahydrofuran and ethanol, and then disperse them in 2 ml of ethanol for storage to obtain BTCA-MC.
[0053] Example 1
[0054] (1) Synthesis of BTCA-COF@PDA particles;
[0055] 1,3,5-Tris(4-aminophenyl)benzene (17.6 mg) and 1,3,5-triformaldehydebenzene (8.1 mg) were dissolved in 39 mL of acetonitrile. Competitors benzaldehyde (60.8 μL) and aniline (54.4 μL) were added. The solution was mixed with 1 mL of acetonitrile containing 11.8 mg of scandium (III) trifluoromethanesulfonate and reacted at room temperature for 24 h. The resulting product (BTCA-COF) was collected, washed with acetonitrile three times, and then transferred to 60 ° C for vacuum drying for 24 h.
[0056] 10 mg of BTCA-COF was added to a mixture containing 10 mL of ethanol and 10 mL of Tris buffer (pH = 8.5). The solution was ultrasonically dispersed for 10 minutes, and then 20 mg of dopamine hydrochloride was added under magnetic stirring. The reaction was carried out at 25 ° C for 6 hours, and then washed three times with ethanol and centrifuged. The product was dried in a vacuum oven at 60 ° C for 24 hours to obtain BTCA-COF@PDA black powder.
[0057] from Figure 1 It can be seen that BTCA-COFs have a uniform spherical morphology, a particle size of about 230 nm, and a smooth surface morphology. After modification with dopamine, the surface morphology is slightly rough.
[0058] (2) Synthesis of BTCA-COF@PDA microspheres;
[0059] First, when preparing COFs particle-stabilized Pickering emulsion, 1.7 mg BTCA-COF@PDA was dispersed in 4 mL of trimethyltoluene using ultrasound. Then, 7.3 mg of scandium (III) trifluoromethanesulfonate was dissolved in 1 ml of deionized water as the aqueous phase. Starting from the aqueous phase, 200 μL was dropped into the above mixture and emulsified under shear stirring at 15,000 rpm for 3 minutes to obtain a stable W / O Pickering emulsion.
[0060] Then, take 2 ml of the above emulsion (containing 100 μL of aqueous phase) and add it to a centrifuge tube together with 4 ml of trimethylbenzene. Dissolve 3.5 mg of 1,3,5-tris(4-aminophenyl)benzene and 1.6 mg of 1,3,5-triformaldehydebenzene BTCA in 2 mL of chloroform, and then add 12.1 μL of benzaldehyde and 10.8 μL of aniline. Add the mixture to the emulsion dispersion. Adjust the density of the solvent to about 1 g / cm by adding chloroform and trimethylbenzene. 3 The polymerization was carried out at room temperature for 24 h. Finally, the microspheres were collected, washed with tetrahydrofuran and ethanol several times, and then dispersed in 2 ml of ethanol to obtain BTCA-COF@PDA-MC.
[0061] (3) Initiator (Y-Shape-(Br) 2 ) and the synthesis of 1-allylpyridine-3-boronic acid (3-APBA);
[0062] Add 2,2-di(hydroxymethyl)propionic acid (2.0 g), triethylamine (5 mL), and tetrahydrofuran (30 mL) to a 100 mL round-bottom flask with a magnetic bar and cool in an ice bath. Add 2-bromoisobutyl bromide (4.2 mL) dissolved in 4 ml of tetrahydrofuran dropwise into the flask. Stir at room temperature for 24 hours. After the reaction is complete, filter out the solid formed and evaporate the solvent. Dissolve the residue in dichloromethane, add 10 mL of water, stir at 50 ° C for 2 hours, and separate the organic layer. Repeat the above steps three times, and after desolvation, a white solid initiator (yield 90%) is obtained.
[0063] Pyridine-3-boric acid (200 mg) and allyl bromide (400 mg) were dissolved in ethanol (50 mL) and reacted at 110° C. under a nitrogen atmosphere for 24 hours. After the reaction was completed, the solvent and unreacted allyl bromide were removed in vacuo.
[0064] like Figure 3 As shown, Figure a is the NMR spectrum of Y-Shape-(Br)2, δ = 1.40 (s, 3H), 1.94 (s, 12H), 4.39 (q, 4H). Figure b is the NMR spectrum of APBA, δ = .24 (d, 2H, (d), (e)), 5.50 (dd, 2H, (a), (b)), 6.17 (ddt, 1H, (c)), 8.04 (ddd, 1H, (f)), 8.74 (dt, 1H, (e)), 8.70-8.99 (ddd, 2H, (g), (h)).
[0065] (4) Synthesis of DR-MC@PDA@MIPs microspheres;
[0066] First, the prepared BTCA-COF@PDA-MC was added to a mixture containing 10 ml of ethanol and 10 ml of Tris buffer (pH = 8.5). Subsequently, 20 mg of dopamine hydrochloride was added under magnetic stirring. The mixture was reacted at 25 °C for 12 hours, and then washed with ethanol several times to collect dopamine-functionalized microspheres, namely MC@PDA.
[0067] Then, 50.0 mg of Y-Shape-(Br) 2 Dissolve in 10 mL of ethanol, add 22.2 mg of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and 13.3 mg of n-hydroxysuccinimide (NHS), and react for 5.0 min. Add MC@PDA dispersed in 10 mL of deionized water (pH = 6.0) to the above solution, stir at 35 ° C for 12 h, and wash the obtained product MC@PDA-Br with ethanol and deionized water several times.
[0068] The synthesized low pKa boronic acid monomer (3-APBA, 1.4 mg) and NRG (29 mg) were dispersed in a mixed solvent of methanol (5.0 mL) and N,N-dimethylformamide (5.0 mL) and incubated for 3.0 h to induce covalent assembly. The prepared MC@PDA-Br was then added to the above solution. Under nitrogen protection, 1.3 mg of copper dichloride and 1.7 mg of N,N,N',N",N"-pentamethyldiethylenetriamine were added sequentially with magnetic stirring. After 10 minutes, 3.5 mg of ascorbic acid was added, and molecular imprinting polymerization was initiated by SI-ATRP at 25 °C for 12.0 h. Finally, the template NRG was removed with a mixture of methanol / acetic acid (v:v, 9:1) and washed with water and ethanol. The obtained DR-MC@PDA@MIPs were dried in a vacuum oven at 40 °C for 12 h.
[0069] For comparison, non-imprinted polymers (DR-MC@PDA@NIPs) were prepared using the same method without the addition of NRG.
[0070] like Figure 2 As shown, the microspheres have a continuous shell layer. Due to the presence of COFs stabilizers, many COFs particles gather on the outer surface, and the shell layer can grow continuously inward in an aqueous environment. Through subsequent layer-by-layer modification, the surface of the microspheres gradually becomes rough, eventually leading to the growth of a double-imprinted shell layer on the surface of the microspheres.
[0071] like Figure 4 As shown, C, N, O, and B elements are evenly distributed on the surface of the microspheres. With the introduction of the boric acid ligand, along with the appearance of the B element, it is shown that the imprinted polymer MC@PDA@MIPs was successfully prepared by SI-ATRP.
[0072] Test Example 1
[0073] 5 mg of DR-MC@PDA@MIPs was weighed and added to 5 mL of NRG solution (35 mg / L, pH = 7.4). Under 308K water bath oscillation, the contact time between the adsorbent and the solution was 5 min, 10 min, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 180 min, 240 min, and 300 min, respectively. The residual NRG concentration at the corresponding time t was determined by UV-Vis method, and the adsorption capacity was calculated based on the results. Figure 5 As shown in the figure, DR-MC@PDA@MIPs exhibited rapid absorption characteristics within 0-60 minutes, and the binding process gradually approached equilibrium at 120 minutes. This is because as the adsorption time increases, the imprinting sites are gradually occupied, resulting in a gradual increase in the adsorption capacity until equilibrium is reached.
[0074] Test Example 2
[0075] Weigh 5 mg of DR-MC@PDA@MIPs and add 5 mL of NRG solution (pH = 7.4) of different concentrations (10, 15, 25, 35, 50 mg / L), and oscillate in a constant temperature water bath at 298K, 303K, and 308K for 360 min. After adsorption, the residual NRG concentration was determined by UV-Vis method, and the adsorption capacity was calculated based on the results. The adsorption capacity of DR-MC@PDA@NIPs was calculated in the same way. Figure 6 As shown, at various initial concentrations and temperatures, the boron affinity porous microsphere imprinted adsorbent DR-MC@PDA@MIPs ( Figure 6 a) are higher than the boron affinity microsphere non-imprinted adsorbent DR-MC@PDA@NIPs ( Figure 6 b) has a high adsorption capacity.
[0076] Test Example 3
[0077] Rutin (RT), quercetin (QU), o-nitrophenol (ON), alizarin red (ARS) and hydroquinone (HQ) were selected as competitive adsorbents, among which RT, QU and ARS have cis-diol structures similar to NRG. 5.0 mg DR-MC@PDA@MIPs were immersed in 5.0 mL of the above hydroxyl compound aqueous solution (pH = 7.4, 35 mg / L). Then adsorbed in a 308K water bath for 6.0 h, the supernatant was centrifuged and the concentration of the competitor was determined by UV-Vis method. Figure 7As shown, compared with other competing molecules, DR-MC@PDA@MIPs has a significantly higher adsorption capacity for NRG, which is attributed to the abundant imprinted recognition sites on its surface, indicating that DR-MC@PDA@MIPs has a significant specific recognition for naringin.
Claims
1. A method for preparing a boron affinity imprinted COF microsphere adsorbent, characterized in that: The steps include: (1) Synthesis of BTCA-COF@PDA particles; Dissolve 1,3,5-tris(4-aminophenyl)benzene and 1,3,5-triformaldehydebenzene in acetonitrile, add competitor benzaldehyde and aniline, mix the solution with acetonitrile containing scandium(III) trifluoromethanesulfonate, react at room temperature for 12-48 hours, collect the resulting product BTCA-COF, wash with acetonitrile and transfer to a vacuum oven for drying; BTCA-COF was added to a mixture containing ethanol and Tris buffer, the solution was ultrasonically dispersed, and then dopamine hydrochloride was added under magnetic stirring. The reaction was carried out at room temperature for 5-10 hours, and then washed three times with ethanol, centrifuged, and vacuum dried to obtain BTCA-COF@PDA black powder; (2) Synthesis of microsphere BTCA-COF@PDA-MC; First, BTCA-COF@PDA was dispersed in trimethyltoluene by ultrasonication as the oil phase; then, scandium (III) trifluoromethanesulfonate was dissolved in deionized water to obtain a scandium (III) trifluoromethanesulfonate aqueous solution as the water phase, which was dropped into the oil phase and emulsified under high-speed shear stirring to obtain a stable W / O Pickering emulsion; Then, the emulsion and trimethyl toluene were added into a centrifuge tube to obtain an emulsion dispersion; 1,3,5-tri(4-aminophenyl)benzene and 1,3,5-triformaldehydebenzene BTCA were dissolved in chloroform, and then benzaldehyde and aniline were added to obtain a mixture; the mixture was added into the emulsion dispersion, and after polymerization at room temperature, microspheres were collected, and washed with tetrahydrofuran and ethanol for several times to obtain microspheres BTCA-COF@PDA-MC; (3) Synthesis of initiator (Y-Shape-(Br)2) and 1-allylpyridine-3-boronic acid (3-APBA); Add 2,2-di(hydroxymethyl)propionic acid, triethylamine and tetrahydrofuran into a round-bottom flask with a magnetic bar, cool in an ice bath, drop 2-bromoisobutyl bromide dissolved in tetrahydrofuran into the flask, stir at room temperature for 1-3 hours, after the reaction is completed, filter out the formed solid, evaporate the solvent, dissolve the residue in dichloromethane, add deionized water, stir at 40-60°C for 1-3 hours, separate the organic layer, extract several times, and remove the solvent to obtain a white solid initiator Y-Shape-(Br)2; Dissolve pyridine-3-boric acid and allyl bromide in ethanol, react under nitrogen atmosphere at 100-150° C. for 12-36 hours, and after the reaction, remove the solvent and unreacted allyl bromide in vacuo to obtain 3-APBA; (4) Synthesis of DR-MC@PDA@MIPs microspheres; First, the BTCA-COF@PDA-MC prepared in step (2) is added to a mixture containing ethanol and Tris buffer, and then dopamine hydrochloride is added under magnetic stirring. After reacting at room temperature for 8-16 hours, the microspheres are washed with ethanol and dopamine functionalized microspheres, i.e., MC@PDA, are collected. Then, the Y-Shape-(Br)2 prepared in step (3) was dissolved in ethanol, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and n-hydroxysuccinimide were added, and the mixture was reacted for 5-10 min, and then MC@PDA dispersed in deionized water was added, and the mixture was stirred at 25-45°C for 10-15 h to obtain MC@PDA-Br, which was then washed with ethanol and deionized water several times; 3-APBA and naringin NRG were dispersed in a mixed solvent of methanol and N,N-dimethylformamide, and then MC@PDA-Br was added. The mixture was magnetically stirred under nitrogen protection, and copper dichloride and N,N,N',N",N"-pentamethyldiethylenetriamine were added in sequence. After 10 to 15 minutes, ascorbic acid was added and molecular imprinting polymerization was initiated by SI-ATRP at room temperature for 10-15 hours. Finally, the template NRG was removed with a mixture of methanol and acetic acid, washed with water and ethanol, and vacuum dried to obtain DR-MC@PDA@MIPs, i.e., boron affinity imprinted COF microsphere adsorbent.
2. The preparation method according to claim 1, characterized in that In step (1), the ratio of 1,3,5-tris(4-aminophenyl)benzene, 1,3,5-triformaldehydebenzene, benzaldehyde, aniline, and scandium(III) trifluoromethanesulfonate is (17-36) mg: (8-17) mg: (60-125) μL: (50-120) μL: (10-25) mg; The dosage ratio of BTCA-COF and dopamine hydrochloride is (10-20) mg: (10-20) mg.
3. The preparation method according to claim 1, characterized in that: In step (2), the usage ratio of BTCA-COF@PDA, trimethyltoluene, and scandium (III) trifluoromethanesulfonate aqueous solution is (1.7-3.4) mg: (4-8) mL: (200-400) μL; wherein the concentration of the scandium (III) trifluoromethanesulfonate aqueous solution is 7.3 mg / mL.
4. The preparation method according to claim 1, characterized in that: In step (2), the usage ratio of W / O Pickering emulsion, trimethyltoluene, 1,3,5-tris(4-aminophenyl)benzene, 1,3,5-triformaldehydebenzene, chloroform, benzaldehyde and aniline is (2-4) mL: (4-8) mL: (3.5-7.0) mg: (1.6-3.2) mg: (2-4) mL: (12.1-24.2) μL: (10.8-21.6) μL.
5. The preparation method according to claim 1, characterized in that: In step (3), the ratio of 2,2-di(hydroxymethyl)propionic acid, triethylamine, 2-bromoisobutyl bromide and total tetrahydrofuran is (2.0-4.0) mg: (5-10) mL: (3-9) mL: (30-60) mL.
6. The preparation method according to claim 1, characterized in that: In step (3), the usage ratio of pyridine-3-boric acid, allyl bromide and ethanol is (200-400) mL: (400-800) mg: (50-100) mL.
7. The preparation method according to claim 1, characterized in that: In step (4), The dosage ratio of BTCA-COF@PDA-MC, ethanol, Tris buffer and dopamine hydrochloride is (20-40) mg: (10-20) mL: (10-20) mL: (20-40) mg; the pH of Tris buffer is 8.5; The usage ratio of Y-Shape-(Br)2, ethanol, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and n-hydroxysuccinimide is (50-100) mg: (10-20) mL: (20-40) mg: (10-20) mg.
8. The preparation method according to claim 1, characterized in that: In step (4), The dosage ratio of 3-APBA, naringin, methanol and N,N-dimethylformamide is (1.2-2.4) mg: (29-38) mg: (5-10) mL: (5-10) mL; The usage ratio of cupric chloride, N,N,N',N",N"-pentamethyldiethylenetriamine and ascorbic acid is (1.3-2.7) mg: (1.7-3.5) mg: (3.5-7.0) mg.
9. Use of the boron affinity microsphere molecular imprinting adsorbent prepared by the preparation method according to any one of claims 1 to 8 for the selective separation of flavonoid compounds.
10. The use according to claim 9, characterized in that Use of boron affinity imprinted COF microsphere adsorbent for the selective separation of naringin.
